Summary
The product Aromamed 25, manufactured by Deus Medical, was analyzed to verify its composition and potency. The sample, identified by batch number DM09106 with a manufacturing date of October 2020, was tested by Janoshik Analytical, a laboratory known for its expertise in pharmaceutical quality testing. The analysis confirmed the presence of Exemestane, with measured concentrations of 24.93 mg in the first pill and 24.74 mg in the second pill. These values closely match the labeled specification of 25 mg, with a negligible variance of 0.28% and 1.04% below the label claim, respectively. These findings indicate that the product is accurately dosed.
The testing process was initiated on 13 November 2020, with the sample received on 18 November 2020, and the analysis completed on 20 November 2020. As the sample was submitted and paid for by the reseller, DeusPower.shop, the results warrant careful interpretation. This report is published for educational purposes, aiming to help consumers make informed decisions about the quality and consistency of anabolic steroid products.
Detailed Report
Product Overview
- Manufacturer: Deus Medical
- Product Name: Aromamed 25
- Active Ingredient: Exemestane
- Batch Number: DM09106
- Manufacture Date: October 2020
- Expiration Date: Not provided
- Delivery Method: Oral (pill)
Sample Acquisition and Testing
- Task Number: #09128
- Testing Ordered: 13 November 2020
- Sample Received: 18 November 2020
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DeusPower.shop (Reseller)
- Analysis Paid For By: DeusPower.shop (Reseller)
Testing Results
- Specification: 25 mg/pill (as stated on the label)
- Measured Concentration:
- First Pill: 24.93 mg (0.28% below the label claim)
- Second Pill: 24.74 mg (1.04% below the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/09128_WVWUC3ZCDIB4
- Originally Published: https://thinksteroids.com/community/forums/analytical-lab-testing/
Evaluation of Reseller-Funded Testing
This report was submitted and funded by the reseller, DeusPower.shop, necessitating a critical review of the findings. Reseller-funded testing may involve selective sample submission or potential bias in the choice of batch. However, Janoshik Analytical’s history of transparency and consistent methodology lends credibility to these results. For additional validation, cross-referencing with third-party or independent testing is recommended to confirm product quality across multiple batches.
Conclusion
The analysis confirms that Aromamed 25 by Deus Medical contains an accurate dosage of Exemestane, with concentrations measured at 24.93 mg and 24.74 mg per pill. These results closely align with the labeled specification, demonstrating the product’s reliability. This report provides valuable insights for harm reduction and educational purposes, encouraging responsible use and further independent validation to reinforce consumer confidence.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
